| abstract |
Embodiments of the methods of the present disclosure allow interpretation of the 18 F and 18 F-FDG tissue distribution, even though the two radiopharmaceuticals are administered at the same time. This approach is based on the eventual localization of the 18 F almost exclusively to the skeletal structures. Another aspect of the disclosure is a computer-based method for overlapping PET and CT scan images obtained after the simultaneous administration of 18 F and 18 F-FDG, thereby proving improved clarity and detection of malignancies. |